Case Report: Iliopsoas Hematoma during the Clinical Course of Severe COVID-19 in Two Male Patients
抄録
Anticoagulation plays a major role in reducing the risk of systematic thrombosis in patients with severe COVID-19. Serious hemorrhagic complications, such as intracranial hemorrhage, have also been recognized. However, intra-abdominal hemorrhage is under-recognized because of its rare occurrence, despite high mortality. Here, we discuss two cases of spontaneous iliopsoas hematoma (IPH) likely caused by anticoagulants during the clinical course of COVID-19. We also explored published case reports to identify clinical characteristics of IPH in COVID-19 patients. The use of anticoagulants may increase the risk of lethal IPH among COVID-19 patients becsuse of scarce data on optimal dosage and adequate monitoring of anticoagulant effects. Rapid diagnosis and timely intervention are crucial to ensure good patient outcomes.
収録刊行物
-
- The American Journal of Tropical Medicine and Hygene
-
The American Journal of Tropical Medicine and Hygene 104 (3), 1018-1021, 2021-01-13
The American Society of Tropical Medicine and Hygiene
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1050013552710420224
-
- ISSN
- 14761645
- 00029637
-
- HANDLE
- 20.500.12000/0002019618
-
- 本文言語コード
- en
-
- 資料種別
- journal article
-
- データソース種別
-
- IRDB